Home » Topics » BioWorld Science

BioWorld Science
RSS

Insilico Medicine nominates preclinical candidate targeting 3CL protease for COVID-19

May 25, 2022

In4Derm Limited presents new BRD4 BD2 inhibitors

May 25, 2022

Chinese researchers identify HSP90A inhibitors

May 25, 2022

Sitryx Therapeutics describes new NFE2L2 activators

May 25, 2022

Shanghai Blueray Biopharma discloses PTPN11 mutant inhibitors

May 25, 2022

Adorx Therapeutics patents new CD73 inhibitors

May 25, 2022

MT-101: a potent and small molecule alpha4beta7 integrin inhibitor

May 25, 2022

Antigen-specific immunotolerance platform shows preclinical proof of concept for Parkinson's disease

May 24, 2022

Quoin enters research agreement with QUT to target VCAM-1:VL-4 interaction to treat scleroderma

May 24, 2022

Elicio shows AMP vaccination significantly enhances TCR-T antitumor response in tumor model

May 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...